Download FREE Report Sample
Download Free sampleTopical recombinant human thrombin is a topical thrombin used when capillaries and venules oozing blood and minor bleeding are available and the bleeding is controlled by standard surgical techniques such as sutures, ligation, or cautery. When ineffective or impractical in the population, it can assist in hemostasis.
Topical Recombinant Human Thrombin Market contains market size and forecasts of Topical Recombinant Human Thrombin in global, including the following market information:
Global Topical Recombinant Human Thrombin Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Topical Recombinant Human Thrombin Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Topical Recombinant Human Thrombin companies in 2021 (%)
The global Topical Recombinant Human Thrombin market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
2000/Bottle Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Topical Recombinant Human Thrombin include Baxter, Suzhou Zelgen Biopharmaceuticals and Pfizer, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Topical Recombinant Human Thrombin manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Topical Recombinant Human Thrombin Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Topical Recombinant Human Thrombin Market Segment Percentages, by Type, 2021 (%)
2000/Bottle
5000/Bottle
Others
Global Topical Recombinant Human Thrombin Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Topical Recombinant Human Thrombin Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Global Topical Recombinant Human Thrombin Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Topical Recombinant Human Thrombin Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Topical Recombinant Human Thrombin revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Topical Recombinant Human Thrombin revenues share in global market, 2021 (%)
Key companies Topical Recombinant Human Thrombin sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Topical Recombinant Human Thrombin sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Baxter
Suzhou Zelgen Biopharmaceuticals
Pfizer
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
